Welcome to our dedicated page for Dover SEC filings (Ticker: DOV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Dover Corporation filings document the regulatory record of a diversified global manufacturer with common stock and debt securities registered on the New York Stock Exchange. Recent Form 8-K reports cover operating and financial results, Regulation FD communications, unsecured revolving credit arrangements, replacement or termination of credit agreements, and debt offerings under shelf-registration and indenture documents.
Proxy materials cover annual meeting governance subjects, including board and compensation matters. The filing record also identifies capital-structure items such as Dover common stock and listed notes, along with material-event disclosures tied to financing activity, securities registration, and recurring operating updates.
Dover Corporation (DOV) reported an insider equity award to one of its directors. On 11/17/2025, the reporting person received 972 deferred stock units of Dover common stock at a price of $180.05 per share. These deferred stock units will be settled in an equal number of common shares when the director’s board service ends.
After this grant, the director beneficially owns 170,016 shares of Dover common stock, held directly. The filing shows no derivative securities positions in Table II, indicating the reported activity relates solely to non-derivative equity compensation.
Dover Corporation director reports routine equity grant
A Dover Corporation director filed a Form 4 reporting an award of 972 deferred stock units of Dover common stock on 11/17/2025 at a reference price of $180.05 per share. After this grant, the reporting person beneficially owns 4,959 shares of Dover common stock in total on a direct basis.
The filing explains that these deferred stock units will convert into the same number of Dover common shares when the director’s service on the board ends, providing equity-based compensation that aligns the director’s interests with long-term shareholder value.
Dover Corporation director reports open-market share purchase
A Dover Corporation director reported buying 972 shares of Dover common stock on 11/17/2025 at a price of $180.05 per share. Following this transaction, the director beneficially owns 8,065 Dover shares in total, held directly. The filing is reported on a Form 4 as a change in insider ownership under securities regulations.
Dover Corporation (DOV) reported an insider equity award for one of its directors. On 11/17/2025, the director received 972 deferred stock units of Dover common stock at a reference price of $180.05 per share. These deferred stock units will be settled in the same number of common shares when the director’s board service ends.
After this grant, the director beneficially owns 2,904 shares of Dover common stock in direct ownership. This filing is a routine disclosure of director compensation in equity form, rather than an open-market purchase or sale.
Dover Corporation (DOV) director equity grant reported
A Dover Corporation director reported receiving 972 shares of common stock as a grant of deferred stock units on 11/17/2025. The grant is recorded at a price of $180.05 per share and increases the director’s directly held Dover common stock to 11,931 shares following the transaction.
The deferred stock units will be settled in an equal number of Dover common shares when the director’s service on the board ends, aligning the director’s compensation with long-term shareholder value.
Dover Corporation director reports open-market stock purchase. A Dover Corp (DOV) director acquired 972 shares of common stock in a transaction dated 11/17/2025 at a price of $180.05 per share. Following this purchase, the director beneficially owns 10,506 shares, held directly. The filing is made on Form 4 for a single reporting person and reflects a straightforward increase in the director’s personal ownership stake in Dover Corporation.
A director of Dover Corporation (DOV) reported buying additional company stock. On 11/17/2025, the director acquired 972 shares of Dover common stock at a price of $180.05 per share. After this transaction, the director beneficially owns 2,034 shares, held in direct ownership. The filing does not list any derivative securities transactions, indicating this report focuses on a straightforward purchase of common stock by a board member.
Dover Corporation completed a primary debt offering of €550,000,000 aggregate principal amount of 3.500% Notes due 2033. The notes were issued under Dover’s automatic shelf registration (Form S-3ASR) using a base prospectus dated February 24, 2023 and a prospectus supplement dated November 5, 2025.
The notes are senior unsecured obligations ranking pari passu with Dover’s other senior unsecured debt, and are not convertible or exchangeable. They mature on November 12, 2033. Interest accrues from November 12, 2025 and is payable annually on November 12 of each year, beginning November 12, 2026, calculated on an ACTUAL/ACTUAL (ICMA) basis.
The offering was underwritten by a syndicate including Merrill Lynch International, Citigroup Global Markets Limited, ING Bank N.V., Deutsche Bank AG, London Branch, Goldman Sachs & Co. LLC, and others. A legal opinion regarding the notes was provided by Dover’s General Counsel.
Dover Corporation entered into an accelerated share repurchase program with JPMorgan Chase Bank, N.A. to repurchase $500 million of its common stock. The buyback is under a board authorization for up to 20,000,000 shares approved in August 2023. Dover expects to receive approximately 2,334,010 shares on November 12, 2025, representing a substantial majority of the shares anticipated to be retired through the program, and plans to fund the repurchases with cash on hand.
The final share count will be determined by the average daily volume‑weighted average price of the stock during the ASR term, less a discount and subject to adjustments. Final settlement is expected in Q2 2026, and the ASR may be terminated early in certain circumstances.
Dover (DOV) reported Q3 2025 results. Revenue rose to $2,077,841 from $1,983,542 a year ago as gross profit improved. Operating earnings were $377,153 versus $333,617. Diluted EPS from continuing operations was $2.20 (vs. $2.26), and diluted net EPS was $2.19 (vs. $2.51), reflecting the prior year's gains on dispositions and lower discontinued operations benefit.
Year‑to‑date cash from operations increased to $794,059. Investing cash flow reflected acquisitions of $663,194, led by the Sikora AG purchase for $608,401, plus Cryo‑Mach, ipp and Site IQ. Goodwill reached $5,403,860 and intangible assets, net, were $1,810,211. Cash was $1,552,804, long‑term debt $2,670,362, and stockholders’ equity $7,662,936.
Discontinued operations (ESG) recorded a quarterly loss of $1,296 after post‑closing adjustments. A jury returned a $58.9 million verdict related to ESG; the company filed post‑trial motions and has not recognized an expense. Contract liabilities (current) were $183,440, and the company estimates $333,272 of remaining performance obligations to be recognized over future periods. Shares outstanding were 137,153,223 as of October 17, 2025.